Subtle Gaze Direction May Help Train Future Radiologists

Subtle Gaze Direction May Help Train Future Radiologists

Researchers at Washington University in St. Louis have shown that a simple visual technique called “subtle gaze direction,” in which gentle visual cues are used to guide a viewer’s gaze, can be an effective technique to help radiology students learn how to study a mammogram.

The technique takes advantage of our vision’s quick response to brightness, color, and contrast changes in the periphery, which almost forces the eye to move toward the changing scene. By recording an experienced radiologist’s eye movements and using those to steer the gaze of novices, the researchers were able to show that the newbies improved their accuracy in detecting potential tumors better than the control group.

Read More

Cell Freeze Cryogenic Storage Containers for HPC’s OK’ed in Europe

Cell Freeze Cryogenic Storage Containers for HPC's OK'ed in Europe

Charter Medical, a part of Lydall (Manchester, CT), received the EU CE Mark for its Cell Freeze cryogenic storage containers for Hematopoietic Progenitor Cells (HPC’s). The devices, which were approved just over a year ago in the U.S., can safely go down to -200° C and handle temperature changes common to stem cell applications. They’re available in sizes from 50 mL to 750 mL.

Press release: Charter Medical Receives CE Mark Clearance for Next Generation Cell Freeze(R) Cryogenic Stem Cell Storage Containers

Read More

Doctors in Tech: Interview with Medical Device Entrepreneur Kathy Stecco

Doctors in Tech: Interview with Medical Device Entrepreneur Kathy Stecco

Medgadget recently had the opportunity to interview Kathryn Stecco, MD, a globetrotting surgeon and an entrepreneur in the medical device space. Stecco is at once a medical consultant and monitor at BaroSense Inc., a surgical consultant at Mach Labs L.P., medical director of Nfocus Neuromedical Inc., and an external consultant to AKA Lifesciences. Dr. Stecco, who calls Silicon Valley home, has worked with local medical device legends Thomas Fogarty, MD and Mir Imran.

In this interview, she explains how studying medicine helped prepare her for working in the device field, and shares advice with physicians looking to follow a similar path to hers.

Read More

Big Bass Powers Detection of Dropped Beats

Big Bass Powers Detection of Dropped Beats

André Romelle Young may just earn his self-given stage name, Dr. Dre, thanks to the innovative work of Purdue University researchers. The team discovered that acoustic waves from music, especially rap with its emphasis on bass, could be useful as power sources for implantable medical devices.

Their proof of concept was a microelectromechanical system (MEMS) capable of sensing pressure. The press release describes how the sensor operates and is charged:

Read More

Medtronic’s Aquamantys SBS 5.0 Sheathed Bipolar Sealer Cleared in U.S. for Spinal Surgeries

Medtronic's Aquamantys SBS 5.0 Sheathed Bipolar Sealer Cleared in U.S. for Spinal Surgeries

Medtronic received FDA 510(k) clearance to market its Aquamantys SBS 5.0 Sheathed Bipolar Sealer for sealing soft tissue and epidural veins during spinal surgery.

The device delivers RF energy for cauterization and saline to keep the area clean and clear for easy access around sensitive tissue.

Read More

AdvaMed 2012 Calling for Panel Proposals

advamed 2012 AdvaMed 2012 Calling for Panel ProposalsAdvaMed 2012, the big medtech conference for industry executives, has launched its website and is calling for proposals for program panels.

This year AdvaMed is moving to Boston, a major medtech hub, and that should give the event a somewhat different direction from the one when it was held in Washington, D.C. for the last few years.

AdvaMed 2012 encourages prospective organizers to submit panels that are novel, timely, relevant and valuable in educational content, impart helpful lessons learned, or share proven best practices and have a global appeal. All panel proposals should include a working title and a suggested list of senior global industry and policy experts as panelists. Executive Workshop submissions should feature interactivity and may be tutorial in nature.

Link: AdvaMed 2012…

Nicadex Device May Become Part of Formal Smoking Cessation Therapy

Nicadex Device May Become Part of Formal Smoking Cessation Therapy

Electronic cigarettes have become a big business as many smokers have opted to choose them over the traditional variety. Lack of actual smoke and tar is a major positive, but being able to “smoke” them even where smoking is not allowed may lead to a greater overall intake of nicotine. Nevertheless, many people bought e-cigarettes as a smoking cessation tool that takes away some of the habit forming qualities of real cigarettes while keeping the ever-addictive nicotine.

CN Creative, Ltd. out of Manchester, UK has raised £2 million ($3.1 million) to help bring to market its Nicadex electronic inhaler for nicotine replacement therapy. The device, which delivers vaporized pharmaceutical-grade nicotine, looks to be very much like a typical e-cigarette, but will undergo clinical trials and is planned to be used as a part of a wider smoking cessation therapy approach.

Read More

DNA Sequencing Moving Into The Clinic; Used to Diagnose Mitochondrial Disease in 42 Children

DNA Sequencing Moving Into The Clinic; Used to Diagnose Mitochondrial Disease in 42 Children

DNA sequencing is slowly making the long anticipated move from the research lab into clinical use. After a few isolated reports last year where it was used to diagnose individual patients, now we see one of the first reports of it being used successfully on a larger scale, in 42 infants suspected of mitochondrial disease.

Mitochondria carry their own DNA but also rely on nuclear DNA for part of their functioning, and mutations in either of the two can cause malfunctioning of the mitochondria. Mitochondrial diseases may lead to a wide variety of symptoms and can be hard to diagnose, despite recent advances in genetic and biochemical tests.

Read More

The Future of InterVapor: Q&A with Uptake’s Chief Medical Officer Steven Kesten

The Future of InterVapor: Q&A with Uptake's Chief Medical Officer Steven Kesten

InterVapor, from Uptake Medical (Tustin, CA), is a non-surgical endoscopic lung volume reduction procedure that uses thermal ablation without leaving foreign materials in the lung. In clinical studies of patients with severe emphysema, InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life. The company has now closed a Series C funding round, which will support commercialization of InterVapor for treatment of severe emphysema. This news comes on the heels of Uptake Medical receiving CE mark approval for InterVapor in September, completing the first commercial use of InterVapor in Germany in November, and recently announcing TGA approval for InterVapor to be marketed in Australia.

Steven Kesten, Chief Medical Officer at Uptake Medical, answered our questions about the company and its technology:

Read More